UNI PHARMA KLEON TSETIS PHARMACEUTICAL LAB S A has a total of 17 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Morocco. Its main competitors in its focus markets pharmaceuticals, medical technology and micro-structure and nano-technology are APTAPHARMA INC, SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI and ZUO YAOWU.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Morocco | 2 | |
#4 | China | 1 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | Serbia | 1 | |
#7 | Russian Federation | 1 | |
#8 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Nanostructure applications | |
#4 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Tseti Ioulia | 13 |
#2 | Ioulia Tseti | 2 |
#3 | Tsetis Kleon | 1 |
#4 | Tseti Julija | 1 |
Publication | Filing date | Title |
---|---|---|
EP2932963A1 | Stable pharmaceutical dosage forms comprising Levothyroxine sodium | |
EP2790695A1 | Pharmaceutical composition comprising (s)-2-(2-oxopyrrolidin-1-yl)butanamid | |
EP2377514A2 | Liquid parenteral formulation comprising a tramadol material and paracetamol | |
EP2389923A1 | Stable ready to use injectable paracetamol formulation | |
EP2283823A1 | Effervescent formulations comprising a phosphonate and methods for their preparation | |
EP2277546A1 | Stable ready to use injectable paracetamol formulation | |
RS50582B | Dry powder comprising levothyroxine sodium administered via inhalator |